Bactiguard Holding AB
STO:BACTI B
Relative Value
The Relative Value of one
BACTI B
stock under the Base Case scenario is
26.53
SEK.
Compared to the current market price of 15.95 SEK,
Bactiguard Holding AB
is
Undervalued by 40%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BACTI B Competitors Multiples
Bactiguard Holding AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Bactiguard Holding AB
STO:BACTI B
|
495.1m SEK | 2.2 | -63.1 | -180.4 | -180.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.3 | 37.5 | 27.2 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
57.3B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29B CHF | 3.6 | 38.1 | 14.6 | 28.5 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.9B DKK | 3.5 | 24.4 | 12.9 | 15.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD | 3.1 | 30.7 | 13.2 | 18.1 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
40.1B CNY | 3.9 | 22.8 | 34 | 34 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.4B GBP | 2.4 | 33.5 | 11.7 | 18.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.3B CNY | 8.6 | 23.8 | 21.4 | 21.4 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 1.1 | -15.8 | 17 | 55.1 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
836.8B JPY | 6.4 | 47.3 | 22.3 | 30.3 |